1 |
Djuricic I, Calder PC. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health. Annu Rev Pharmacol Toxicol 2023;63:383-406. [PMID: 36662586 DOI: 10.1146/annurev-pharmtox-051921-090208] [Reference Citation Analysis]
|
2 |
Berná G, López-bermudo L, Escudero-lópez B, Martín F. We are what we eat: The role of lipids in metabolic diseases. Advances in Food and Nutrition Research 2023. [DOI: 10.1016/bs.afnr.2022.11.004] [Reference Citation Analysis]
|
3 |
Parham JS, Goldberg AC. Review of recent clinical trials and their impact on the treatment of hypercholesterolemia. Prog Cardiovasc Dis 2022;75:90-6. [PMID: 36400233 DOI: 10.1016/j.pcad.2022.11.011] [Reference Citation Analysis]
|
4 |
Li M, Shi Q, Jiang X, Liu X, Han W, Fan X, Li P, Qi K. Paternal preconceptional diet enriched with n-3 polyunsaturated fatty acids affects offspring brain function in mice. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.969848] [Reference Citation Analysis]
|
5 |
Ruscica M, Sirtori CR, Carugo S, Calder PC, Corsini A. OMEGA-3 AND CARDIOVASCULAR PREVENTION – IS THIS STILL A CHOICE? Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Djuricic I, Calder PC. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients 2021;13:2421. [PMID: 34371930 DOI: 10.3390/nu13072421] [Cited by in Crossref: 75] [Cited by in F6Publishing: 85] [Article Influence: 37.5] [Reference Citation Analysis]
|
7 |
Curfman G, Shehada E. Icosapent ethyl: scientific and legal controversies. Open Heart 2021;8:e001616. [PMID: 33888593 DOI: 10.1136/openhrt-2021-001616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|